Royal Bank of Canada
NMTR

Royal Bank of Canada’s 9 Meters Biopharma NMTR Stock Holding History

Royal Bank of Canada’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-134
Closed – – 7942
2023
Q2 		$0 Sell
134
-31
-19% -$27 ﹤0.01% 7900
2023
Q1 		$0 Buy
165
+82
+99% +$155 ﹤0.01% 7706
2022
Q4 		$0 Sell
83
-96
-54% -$219 ﹤0.01% 8010
2022
Q3 		$1K Buy
179
+24
+15% +$119 ﹤0.01% 7354
2022
Q2 		$1K Sell
155
-666
-81% -$6.28K ﹤0.01% 7272
2022
Q1 		$9K Sell
821
-1,936
-70% -$26.4K ﹤0.01% 7021
2021
Q4 		$53K Buy
2,757
+1,279
+87% +$28.6K ﹤0.01% 6349
2021
Q3 		$38K Buy
1,478
+549
+59% +$12.9K ﹤0.01% 6333
2021
Q2 		$21K Buy
929
+779
+519% +$19.1K ﹤0.01% 6548
2021
Q1 		$4K Sell
150
-475
-76% -$14.6K ﹤0.01% 7127
2020
Q4 		$11K Buy
625
+500
+400% +$8.34K ﹤0.01% 6345
2020
Q3 		$2K Sell
125
-37
-23% -$449 ﹤0.01% 6355
2020
Q2 		$1K Buy
162
+6
+4% +$68 ﹤0.01% 6523
2020
Q1 		$1K Buy
156
+56
+56% +$702 ﹤0.01% 6539
2019
Q4 		$1K Sell
100
-93
-48% -$1.55K ﹤0.01% 6721
2019
Q3 		$4K Buy
193
+18
+10% +$364 ﹤0.01% 6138
2019
Q2 		$4K Hold
175
– – ﹤0.01% 6422
2019
Q1 		$7K Hold
175
– – ﹤0.01% 6161
2018
Q4 		$8K Sell
175
-4
-2% -$296 ﹤0.01% 6007
2018
Q3 		$24K Buy
179
+127
+244% +$21.8K ﹤0.01% 5591
2018
Q2 		$25K Buy
+52
New +$19.1K ﹤0.01% 5451

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Royal Bank of Canada's NMTR Position: Q3 2023 in Review

Royal Bank of Canada sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 134 shares.

Royal Bank of Canada first reported a position in NMTR in Q2 2018 and held it in 21 quarters. The position peaked at $53K in Q4 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Royal Bank of Canada reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 134 9 Meters Biopharma shares in Q3 2023.
  • Royal Bank of Canada first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 21 quarters.
  • Royal Bank of Canada's 9 Meters Biopharma position peaked at $53K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.